《精神疾病诊断与统计手册》第三版修订本（DSM-III-R）结构化临床访谈（SCID）。第二部分。多地点重测信度。
The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability.
作者信息
Williams J B, Gibbon M, First M B, Spitzer R L, Davies M, Borus J, Howes M J, Kane J, Pope H G, Rounsaville B
机构信息
Department of Psychiatry, Columbia University, New York, NY.
出版信息
Arch Gen Psychiatry. 1992 Aug;49(8):630-6. doi: 10.1001/archpsyc.1992.01820080038006.
A test-retest reliability study of the Structured Clinical Interview for DSM-III-R was conducted on 592 subjects in four patient and two nonpatient sites in this country as well as one patient site in Germany. For most of the major categories, kappa s for current and lifetime diagnoses in the patient samples were above .60, with an overall weighted kappa of .61 for current and .68 for lifetime diagnoses. For the nonpatients, however, agreement was considerably lower, with a mean kappa of .37 for current and .51 for lifetime diagnoses. These values for the patient and nonpatient samples are roughly comparable to those obtained with other structured diagnostic instruments. Sources of diagnostic disagreement, such as inadequate training of interviewers, information variance, and low base rates for many disorders, are discussed.
在该国四个患者站点和两个非患者站点以及德国一个患者站点，对592名受试者进行了DSM - III - R结构化临床访谈的重测信度研究。对于大多数主要类别，患者样本中当前和终生诊断的kappa值高于0.60，当前诊断的总体加权kappa值为0.61，终生诊断为0.68。然而，对于非患者，一致性要低得多，当前诊断的平均kappa值为0.37，终生诊断为0.51。患者和非患者样本的这些值与其他结构化诊断工具获得的值大致相当。文中讨论了诊断不一致的来源，如访谈者培训不足、信息差异以及许多疾病的低基础率。
Zotero 插件